CAP-1002
CAP-1002-COVID-19-02
Phase 2 mab completed
Quick answer
CAP-1002 for Covid19 is a Phase 2 program (mab) at CAPRICOR THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CAPRICOR THERAPEUTICS, INC.
- Indication
- Covid19
- Phase
- Phase 2
- Modality
- mab
- Status
- completed